JP2019509300A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509300A5 JP2019509300A5 JP2018549447A JP2018549447A JP2019509300A5 JP 2019509300 A5 JP2019509300 A5 JP 2019509300A5 JP 2018549447 A JP2018549447 A JP 2018549447A JP 2018549447 A JP2018549447 A JP 2018549447A JP 2019509300 A5 JP2019509300 A5 JP 2019509300A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- immunogen
- pcv2
- use according
- mycoplasma hyopneumoniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001673669 Porcine circovirus 2 Species 0.000 claims 18
- 230000002163 immunogen Effects 0.000 claims 18
- 229960005486 vaccine Drugs 0.000 claims 16
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims 11
- 230000003362 replicative effect Effects 0.000 claims 11
- 241001148567 Lawsonia intracellularis Species 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 5
- 241001465754 Metazoa Species 0.000 claims 4
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 230000002238 attenuated effect Effects 0.000 claims 3
- 239000007908 nanoemulsion Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 claims 2
- 101710113540 ORF2 protein Proteins 0.000 claims 2
- 101710090523 Putative movement protein Proteins 0.000 claims 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000011707 mineral Substances 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 241000204031 Mycoplasma Species 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16161997.8 | 2016-03-23 | ||
| EP16161997 | 2016-03-23 | ||
| PCT/EP2017/056831 WO2017162741A1 (en) | 2016-03-23 | 2017-03-22 | A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509300A JP2019509300A (ja) | 2019-04-04 |
| JP2019509300A5 true JP2019509300A5 (enExample) | 2020-03-12 |
| JP6907227B2 JP6907227B2 (ja) | 2021-07-21 |
Family
ID=55589754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018549447A Expired - Fee Related JP6907227B2 (ja) | 2016-03-23 | 2017-03-22 | Ｐｃｖ２ウイルス及びマイコプラズマ・ハイオニューモニエ感染症に対する混合ワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190105385A1 (enExample) |
| EP (1) | EP3432919A1 (enExample) |
| JP (1) | JP6907227B2 (enExample) |
| CN (1) | CN108697782A (enExample) |
| BR (1) | BR112018069100A2 (enExample) |
| RU (1) | RU2018137034A (enExample) |
| WO (1) | WO2017162741A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020011044A2 (pt) * | 2017-12-04 | 2020-11-17 | Intervet International B.V. | vacinação com partículas de replicon e adjuvante de óleo |
| JP7510874B2 (ja) * | 2017-12-22 | 2024-07-04 | ヒプラ シエンティフィック エセ．エレ．ウ． | マイコプラズマ及びブタサーコウイルスに対する皮内混合ワクチン |
| US20220323567A1 (en) * | 2019-09-12 | 2022-10-13 | Intervet Inc. | Combination vaccine for intradermal administration |
| EP4138892A1 (en) * | 2020-04-20 | 2023-03-01 | Intervet International B.V. | A vaccine to protect against mycoplasma hyopneumoniae |
| CN115427072A (zh) * | 2020-04-20 | 2022-12-02 | 英特维特国际股份有限公司 | 预防性治疗猪的疫苗组合 |
| WO2025132513A1 (en) | 2023-12-19 | 2025-06-26 | Intervet International B.V. | Low-energy electron irradiation-inactivated mollicutes |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU212924B (en) * | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| JP2006528647A (ja) * | 2003-07-24 | 2006-12-21 | メリアル リミテッド | 新規ワクチン製剤 |
| UA89631C2 (en) * | 2004-04-05 | 2010-02-25 | Пфайзер Продактс Инк. | Vaccine composition |
| ATE462445T1 (de) | 2005-01-13 | 2010-04-15 | Boehringer Ingelheim Vetmed | Prrs-impfstoffe |
| US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| AR054822A1 (es) * | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| DK1926496T3 (da) | 2005-09-09 | 2013-09-30 | Intervet Int Bv | PCV-2-vaccine |
| DK2371383T3 (en) | 2005-12-29 | 2015-11-30 | Boehringer Ingelheim Vetmed | Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs |
| AU2007333857B2 (en) | 2006-12-15 | 2014-05-15 | Boehringer Ingelheim Animal Health USA Inc. | Treatment of pigs with PCV2 antigen |
| TWI449533B (zh) * | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| CA2848163C (en) * | 2011-09-09 | 2020-10-27 | Nanobio Corporation | Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
| CN104043118A (zh) * | 2013-03-11 | 2014-09-17 | 普莱柯生物工程股份有限公司 | 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用 |
| CN103263666B (zh) * | 2013-05-24 | 2019-07-16 | 北京大北农科技集团股份有限公司动物医学研究中心 | 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法 |
| WO2015082457A1 (en) * | 2013-12-03 | 2015-06-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
-
2017
- 2017-03-22 RU RU2018137034A patent/RU2018137034A/ru unknown
- 2017-03-22 US US16/086,690 patent/US20190105385A1/en not_active Abandoned
- 2017-03-22 JP JP2018549447A patent/JP6907227B2/ja not_active Expired - Fee Related
- 2017-03-22 BR BR112018069100-3A patent/BR112018069100A2/pt unknown
- 2017-03-22 CN CN201780014561.9A patent/CN108697782A/zh active Pending
- 2017-03-22 EP EP17711241.4A patent/EP3432919A1/en active Pending
- 2017-03-22 WO PCT/EP2017/056831 patent/WO2017162741A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509300A5 (enExample) | ||
| RU2018137034A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| JP5832061B2 (ja) | ローソニア・イントラセルラリスを含む免疫原性組成物 | |
| JP2015512449A5 (enExample) | ||
| JP2016531854A5 (enExample) | ||
| WO2009126356A3 (en) | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions | |
| BR112014024785B1 (pt) | composições imunogênica multivalente e de vacina e seus uso para imunização contra mycoplasma hyopneumoniae e circovírus suíno tipo 2 e método de preparação, bem como kit compreendendo as ditas composições | |
| AR069216A1 (es) | Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos | |
| RU2019122996A (ru) | Комбинированная вакцина для свиней | |
| RU2017124240A (ru) | СПОСОБ ПОЛУЧЕНИЯ ГОТОВОЙ К ПРИМЕНЕНИЮ КОМБИНИРОВАННОЙ ВАКЦИНЫ ПРОТИВ PCV2/M.hyo | |
| MX2020006662A (es) | Vacuna combinada intradermica contra mycoplasma y circovirus porcino. | |
| MX2022003090A (es) | Vacuna combinada para ser administrable intradermicamente. | |
| JP2025026461A5 (enExample) | ||
| RU2018127403A (ru) | Поливалентная вакцина против hyo и ее применение | |
| DK3076997T3 (en) | SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS | |
| Ravelo et al. | Use of adjuvanted vaccines to lengthen the protection against lactococcosis in rainbow trout (Oncorhynchus mykiss) | |
| BR112016028418A2 (pt) | composição de adjuvante, vacina, anticorpo agonista cd40 ou uma parte desse, composição farmacêutica, construto, célula, e, método de mapeamento de epítopo de um polipeptídeo | |
| JP2023025210A5 (enExample) | ||
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| RU2019136252A (ru) | Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения | |
| JP2019512518A5 (enExample) | ||
| RU2022116197A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| RU2008144180A (ru) | Вакцина против микоплазмы и prrsv | |
| RU2018137033A (ru) | Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs | |
| JP2019509302A5 (enExample) |